Global Plasma Therapy Competitive Landscape Professional Research Report 2024
Research Summary
Plasma therapy, also known as convalescent plasma therapy, is a medical treatment that involves the infusion of plasma from individuals who have recovered from a specific infection into patients currently battling the same disease. The plasma, the liquid component of blood, contains antibodies and other immune factors developed by the recovered individual to combat the infection. In the context of infectious diseases, such as viral illnesses, convalescent plasma may contain antibodies capable of neutralizing the virus. This therapy aims to boost the patient's immune response and assist in fighting the infection. Plasma therapy has been explored in various infectious disease outbreaks, including the treatment of severe cases of COVID-19. While it has shown promise in some instances, its effectiveness can depend on factors like the timing of administration and the specific characteristics of the disease being treated.
According to DIResearch's in-depth investigation and research, the global Plasma Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Plasma Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Plasma Therapy Include:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Product Segment Include:
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Product Application Include:
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Plasma Therapy Industry PESTEL Analysis
Chapter 3: Global Plasma Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Plasma Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Plasma Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Plasma Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources